Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: The role of serotonin and different forebrain neuronal subpopulations

Neuropharmacology

Volumn 65, Issue , 2013, Pages 83-89

  Haring M ^a   Grieb, M ^a   Monory, K ^a   Lutz, B ^a   Moreira, F A ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cannabinoids; Catecholamine; Depression; GABA; Glutamate; Serotonin

Indexed keywords

CANNABINOID 1 RECEPTOR; CATECHOLAMINE; DRONABINOL; FENCLONINE; IMIPRAMINE; METIROSINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RIMONABANT; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; COPING BEHAVIOR; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; FORCED SWIMMING TEST; FOREBRAIN; GABAERGIC TRANSMISSION; LOW DRUG DOSE; MALE; MONOAMINERGIC SYSTEM; MOUSE; NERVE CELL; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; CATECHOLAMINES; GABAERGIC NEURONS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PIPERIDINES; PROSENCEPHALON; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SEROTONIN; STRESS, PSYCHOLOGICAL; TETRAHYDROCANNABINOL;

EID: 84870928503     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.09.002     Document Type: Article

References (49)

1. F.R. Bambico, N. Katz, G. Debonnel, and G. Gobbi Cannabinoids elicit antidepressant-like behaviour and activate serotonergic neurons through the medial prefrontal cortex J. Neurosci. 27 2007 11700 11711
2. F.R. Bambico, T. Cassano, S. Dominguez-Lopez, N. Katz, C.D. Walker, D. Piomelli, and G. Gobbi Genetic deletion of fatty acid amide hydrolase alters emotional behaviour and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus Neuropsychopharmacology 35 2010 2083 2100
3. F.R. Bambico, P.R. Hattan, J.P. Garant, and G. Gobbi Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and postsynaptic serotonergic transmission Prog. Neuropsychopharmacol. Biol. Psychiatry 38 2012 88 96
4. 9-tetrahydrocannabinol Psychopharmacology (Berl) 163 2002 111 117
5. C.E. Beyer, J.M. Dwyer, M.J. Piesla, B.J. Platt, R. Shen, Z. Rahman, K. Chan, M.T. Manners, T.A. Samad, J.D. Kennedy, B. Bingham, and G.T. Whiteside Depression-like phenotype following chronic CB1 receptor antagonism Neurobiol. Dis. 39 2010 148 155
6. 9-tetrahydrocannabinol and AM404, the anandamide transport inhibitor, in Sprague-Dawley rats Eur. J. Pharmacol. 555 2007 156 163
7. A, and glutamate receptors J. Neurosci. 21 2001 9917 9929
8. H. Corrodi, and L.C. Hanson Central effects of an inhibitor of tyrosine hydroxylation Psychopharmacologia 10 1966 116 125
9. J.F. Cryan, and C. Mombereau In search of a depressed mouse: utility of models for studying depression-related behaviour in genetically modified mice Mol. Psychiatry 9 2004 326 357
10. 9-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB1 receptor and serotonergic system Eur. J. Pharmacol. 589 2008 117 121
11. 9- tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L Pharmacol. Biochem. Behav. 95 2010 434 442
12. G. Gobbi, F.R. Bambico, R. Mangieri, M. Bortolato, P. Campolongo, M. Solinas, T. Cassano, M.G. Morgese, G. Debonnel, A. Duranti, A. Tontini, G. Tarzia, M. Mor, V. Trezza, S.R. Goldberg, V. Cuomo, and D. Piomelli Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis Proc. Natl. Acad. Sci. U. S. A. 102 2005 18620 18625
13. B.B. Gorzalka, and M.N. Hill Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 1575 1585
14. G. Griebel, J. Stemmelin, and B. Scatton Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents Biol. Psychiatry 57 2005 261 267
15. W. Hall, and N. Solowij Adverse effects of cannabis Lancet 352 1998 1611 1616
16. M. Häring, G. Marsicano, B. Lutz, and K. Monory Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice Neuroscience 146 2007 1212 1219
17. M. Häring, N. Kaiser, K. Monory, and B. Lutz Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration PLoS One 6 2011 e26617
18. M. Häring, S. Guggenhuber, and B. Lutz Neuronal populations mediating the effects of endocannabinoids on stress and emotionality Neuroscience 204 2012 145 158
19. M.N. Hill, and B.B. Gorzalka Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test Eur. Neuropsychopharmacol. 15 2005 593 599
20. C. Höschl, and J. Svestka Escitalopram for the treatment of major depression and anxiety disorders Expert Rev. Neurother. 8 2008 537 552
21. W. Jacob, A. Yassouridis, G. Marsicano, K. Monory, B. Lutz, and C.T. Wotjak Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission Genes Brain Behav. 8 2009 685 698
22. M.P. Jankowski, and S.R. Sesack Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons J. Comp. Neurol. 468 2004 518 529
23. C.R. Jesse, E.A. Wilhelm, C.F. Bortolatto, and C.W. Nogueira Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice Pharmacol. Biochem. Behav. 95 2010 344 350
24. W. Jiang, Y. Zhang, L. Xiao, J. Van Cleemput, S.P. Ji, G. Bai, and X. Zhang Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic and antidepressant-like effects J. Clin. Invest. 115 2005 3104 3116
25. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol. Rev. 89 2009 309 380
26. 1A receptors in the antidepressant-like effects of adenosine in the forced swim test Brain Res. Bull. 67 2005 53 61
27. P. Lafenêtre, F. Chaouloff, and G. Marsicano Bidirectional regulation of novelty-induced behavioural inhibition by the endocannabinoid system Neuropharmacology 57 2009 715 721
28. M.L. Laorden, M.T. Castells, M.D. Martínez, P.J. Martínez, and M.V. Milanés Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus Endocrinologist 141 2000 1366 1376
29. S.H. Lockie, T.A. Czyzyk, N. Chaudhary, D. Perez-Tilve, S.C. Woods, B.J. Oldfield, M.A. Statnick, and M.H. Tschöp CNS opioid signaling separates cannabinoid receptor 1-mediated effects on body weight and mood-related behavior in mice Endocrinology 152 2011 3661 3667
30. I. Lucki, A. Dalvi, and A.J. Mayorga Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice Psychopharmacology (Berl) 155 2001 315 322
31. F. Massa, G. Mancini, H. Schmidt, F. Steindel, K. Mackie, C. Angioni, S.H. Oliet, G. Geisslinger, and B. Lutz Alterations in the hippocampal endocannabinoid system in diet-induced obese mice J. Neurosci. 30 2010 6273 6281
32. K. Monory, F. Massa, M. Egertova, M. Eder, H. Blaudzun, R. Westenbroek, W. Kelsch, W. Jacob, R. Marsch, M. Ekker, J. Long, J.L. Rubenstein, S. Goebbels, K.A. Nave, M. During, M. Klugmann, B. Wolfel, H.U. Dodt, W. Zieglgansberger, C.T. Wotjak, K. Mackie, M.R. Elphick, G. Marsicano, and B. Lutz The endocannabinoid system controls key epileptogenic circuits in the hippocampus Neuron 51 2006 455 466
33. F.A. Moreira, and J.A. Crippa The psychiatric side effects of rimonabant Rev. Bras. Psiquiatr 31 2009 145 153
34. F.A. Moreira, and B. Lutz The endocannabinoid system: emotion, learning and addiction Addict. Biol. 13 2008 196 212
35. 1 cannabinoid receptors agonist and antagonists: focus on anxiety and depression Best Pract. Res. Clin. Endocrinol. Metab. 23 2009 133 144
36. A.L. Muntoni, G. Pillolla, M. Melis, S. Perra, G.L. Gessa, and M. Pistis Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons Eur. J. Neurosci. 23 2006 2385 2394
37. O.F. O'Leary, A.J. Bechtholt, J.J. Crowley, T.E. Hill, M.E. Page, and I. Lucki Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test Psychopharmacology (Berl) 192 2007 357 371
38. V.C. Oropeza, K. Mackie, and E.J. Van Bockstaele Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex Brain Res. 1127 2007 36 44
39. S. Patel, and C.J. Hillard Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling J. Pharmacol. Exp. Ther. 318 2006 304 311
40. B receptors in the balance of GABAergic and glutamatergic neurotransmission Neuropsychopharmacology 2012 10.1038/npp.2012.123
41. M.A. Steiner, G. Marsicano, E.J. Nestler, F. Holsboer, B. Lutz, and C.T. Wotjak Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice Psychoneuroendocrinology 33 2008 54 67
42. M.A. Steiner, K. Wanisch, K. Monory, G. Marsicano, E. Borroni, H. Bächli, F. Holsboer, B. Lutz, and C.T. Wotjak Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behaviour in mice Pharmacogenomics J. 8 2008 196 208
43. M.A. Steiner, G. Marsicano, C.T. Wotjak, and B. Lutz Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses Psychoneuroendocrinology 33 2008 1165 1170
44. E.T. Tzavara, R.J. Davis, K.W. Perry, X. Li, C. Salhoff, F.P. Bymaster, J.M. Witkin, and G.G. Nomikos The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions Br. J. Pharmacol. 138 2003 544 553
45. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol. Biochem. Behav. 81 2005 331 342
46. A. Weissman, and B.K. Koe Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase Life Sci. 4 1965 1037 1048
47. C.T. Wotjak Role of endogenous cannabinoids in cognition and emotionality Mini. Rev. Med. Chem. 5 2005 659 670
48. 1A receptors Br. J. Pharmacol. 159 2010 122 128
49. 9-THC in normal subjects Psychopharmacology (Berl) 76 1982 245 250